清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial

医学 全直肠系膜切除术 放化疗 临床终点 人口 外科 随机对照试验 结直肠癌 新辅助治疗 腹腔镜手术 腹腔镜检查 临床试验 癌症 内科学 化疗 乳腺癌 环境卫生
作者
Ji Won Park,Sung‐Bum Kang,Jie Hao,Seok‐Byung Lim,Hyo Seong Choi,Duck-Woo Kim,Hee Jin Chang,Dae Yong Kim,Kyung Hae Jung,Tae‐You Kim,Gyeong Hoon Kang,Eui Kyu Chie,Sun Young Kim,Dae Kyung Sohn,Kim Js,Hye Seung Lee,Jee Hyun Kim,Seung‐Yong Jeong,Jae Hwan Oh
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:6 (7): 569-577 被引量:90
标识
DOI:10.1016/s2468-1253(21)00094-7
摘要

Laparoscopic surgery has been widely used for rectal cancer; however, its long-term outcomes remain controversial. This study aimed to assess the long-term oncological safety of laparoscopic surgery for rectal cancer using 10-year follow-up data of the Comparison of Open versus laparoscopic surgery for mid or low REctal cancer After Neoadjuvant chemoradiotherapy (COREAN) trial.The COREAN trial is a, open-label, non-inferiority, randomised controlled trial. Eligible participants were aged 18-80 years, had cT3N0-2M0 middle or low rectal cancer with lesions located within 9 cm of the anal verge, and had been treated with preoperative chemoradiotherapy. Patients were randomly assigned (1:1) to open or laparoscopic surgery with a computer-generated random allocation sequence with a random permuted block design. Neither patients nor clinicians were masked to treatment assignment. Open or laparoscopic total mesorectal excision was done 6-8 weeks after the administration of preoperative concurrent chemoradiotherapy (fluoropyrimidines alone, doublet therapy, or triplet therapy) at a dose of 50·5 Gy over 5·5 weeks. Postoperative adjuvant chemotherapy was administered for 4 months. The primary endpoint of 3-year disease-free survival was published previously. Here, we report 10-year overall survival, disease-free survival, and local recurrence. Analyses were done in the modified intention-to-treat population of all participants who were randomly assigned and provided follow-up data. This study is registered with ClinicalTrials.gov, NCT00470951.Of the 340 patients enrolled in the COREAN trial between April 4, 2006, and Aug 26, 2009 (170 patients in each group), two patients in the laparoscopic surgery group moved abroad and were lost to follow-up, so were not included in this 10-year analysis. The median duration of follow-up was 143 months (IQR 122-156). No differences were observed in 10-year overall survival (74·1% [95% CI 66·8-80·0] in the open surgery group vs 76·8% [69·6-82·5] in the laparoscopic surgery group; p=0·44), 10-year disease-free survival (59·3% [51·1-66·5] vs 64·3% [56·0-71·5]; p=0·20), or 10-year local recurrence (8·9% [5·2-15·0] vs 3·4% [1·4-7·9]; p=0·050) between the open surgery and laparoscopic surgery groups at 10 years after surgery. The stratified hazard ratios, adjusted for ypT and ypN classification and tumour regression grade, for open surgery versus laparoscopic surgery were 0·94 (95% CI 0·63-1·43) for overall survival, 1·05 (0·74-1·49) for disease-free survival, and 2·22 (0·78-6·34) for local recurrence.The 10-year follow-up of the COREAN trial confirms the long-term oncological safety of laparoscopic surgery in patients with rectal cancer treated with preoperative chemoradiotherapy. Similar to open surgery, laparoscopic surgery does not compromise long-term survival outcomes in rectal cancer when performed by well trained surgeons.National Cancer Center, Goyang, South Korea.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
紧张的幼蓉完成签到,获得积分10
19秒前
39秒前
39秒前
文静飞松完成签到,获得积分10
50秒前
修渊完成签到 ,获得积分10
1分钟前
温暖的大船完成签到,获得积分10
1分钟前
波爷完成签到,获得积分10
1分钟前
科研通AI6.3的应助被amiee采纳,获得10
1分钟前
lianxin完成签到 ,获得积分10
1分钟前
ABC完成签到 ,获得积分10
2分钟前
2分钟前
云彦完成签到,获得积分10
2分钟前
李木禾完成签到 ,获得积分10
2分钟前
耍酷的雨泽完成签到,获得积分10
2分钟前
arniu2008的应助被科研通管家采纳,获得80
2分钟前
2分钟前
2分钟前
2分钟前
打打的应助被科研通管家采纳,获得10
2分钟前
2分钟前
甜美达完成签到 ,获得积分10
2分钟前
Panda2022完成签到,获得积分10
2分钟前
范白容完成签到 ,获得积分0
2分钟前
2分钟前
Aria发布了新的文献求助10
3分钟前
王志新完成签到 ,获得积分10
3分钟前
Panda2022发布了新的文献求助30
3分钟前
3分钟前
舒服的月饼完成签到 ,获得积分10
3分钟前
chen发布了新的文献求助10
3分钟前
可爱的一兰完成签到,获得积分10
3分钟前
3分钟前
wuyouping完成签到,获得积分10
3分钟前
amiee发布了新的文献求助10
3分钟前
3分钟前
alandan完成签到,获得积分10
3分钟前
alandan发布了新的文献求助10
3分钟前
睡不醒完成签到 ,获得积分10
4分钟前
urah关注了科研通微信公众号
4分钟前
深情的从丹完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190226
求助须知:如何正确求助?哪些是违规求助? 9577354
关于积分的说明 21852358
捐赠科研通 7788708
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560092
邀请新用户注册赠送积分活动 2482902